LOS Homepage

Advocacy

OSS-Advocacy-Legislative-Center-385x247

Move the Needle on Key Policy Priorities

Explore the Action Center

UPCOMING EVENTS

Check Back for Updates!

Oncology News

FDA Approves Blinatumomab for 72- and 96-Hour Infusion Durations

FDA Grants Accelerated Approval to Encorafenib With Cetuximab and mFOLFOX6 for Metastatic Colorectal Cancer With a BRAF V600E Mutation

FDA Approves Remestemcel-L-rknd for Steroid-Refractory Acute Graft Versus Host Disease in Pediatric Patients

FDA Approves Ensartinib for ALK-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

FDA Approves Cosibelimab-ipdl for Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

VODCAST

Sanjay Juneja Video Podcast

Is It Time to Cancel the Term “A Cure for Cancer”